Injured by Reglan side effects?
On February 26, 2009 the U.S. Food & Drug Administration (FDA) added a "Black Box Warning" to metoclopramide-containing drugs, including Reglan tablets, Reglan oral disintegrating tablets, metoclopramide oral solution, and Reglan injections.
The warning is due in part to a study that linked Reglan (metoclopramide) to being the most common cause of drug-induced movement disorders. More specifically, Reglan has been directly linked to the development of Tardive Dyskinesia.
Reglan is a drug used to treat gastrointestinal disorders. Chronic use of Reglan has been linked to Tardive Dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken. The development of this condition is directly related to the length of time a patient is taking Reglan and the number of doses taken. Those at greatest risk include the elderly, especially older women, children and people who have been on the drug for a long time.
Tardive Dyskinesia is characterized by involuntary, repetitive movements of the extremities, or lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers. These symptoms are rarely reversible and there is no known treatment.
Free Case Evaluation - We offer proven representation in defective drug and products liability cases, serving clients in the Kansas City metro area and throughout Missouri and Kansas. Call 816.421.6868.
If you or a loved one have taken Reglan and subsequently developed Tardive Dyskineisa, you should contact our Kansas City law office at 816.421.6868 or by e-mail. We provide a free, one-on-one consultation with an experienced attorney.
